BCG polysaccharide and nucleic acid (Jilin Yatai Bio-Pharmaceutical)

卡介菌多糖核酸注射液(吉林亚泰)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBCG polysaccharide and nucleic acid (Jilin Yatai Bio-Pharmaceutical)
Drug Alias NameN/A
ClassificationNatural product/Extract > Microbial extractBiologics
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAsthmaCommon ColdBronchitis, Chronic
Global Approved IndicationsAsthmaCommon ColdBronchitis, Chronic
Approved Indications in ChinaAsthmaCommon ColdBronchitis, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date2004/06/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJilin Yatai (Group) Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAsthmaCommon ColdBronchitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeL03AX
Related LinksN/A